OPC1
Asset
- Stage
- Phase 2
- Modality
- Cell therapy
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Spinal cord injury
Phase 2, lineagecell.com, 10 Oct 2026
In the full profile
- Owner and partners1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.